Get the Stockscreener App
129.98
5.24%
6.47
After Hours:
129.90
-0.08
-0.06%
Jazz Pharmaceuticals Plc Stock (JAZZ) Latest News
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 - ShareCast
Jazz Pharmaceuticals Q4 Earnings: Key Financial Results and Strategic Updates Coming Soon - StockTitan
Jazz Pharmaceutical wraps up Epidiolex patent claims - Green Market Report
Moloney Securities Asset Management LLC Acquires New Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharma Drops Last Defendant From Epidiolex Patent Suit - Law360
Avadel Pharmaceuticals gains as holder pushes for sale process (AVDL:NASDAQ) - Seeking Alpha
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors - Yahoo Finance
Meritage Portfolio Management Has $8.16 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Graphene Investments SAS Sells 2,800 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Bruce C. Cozadd Sells 1,500 Shares of Stock - MarketBeat
Fed Circ. Considers Some Testing For Avadel Sleep Drug - Law360
Jazz Pharmaceuticals Joins the Movement for Awareness and Support on World Cancer Day with The Upside Down Challenge - StreetInsider.com
Jazz Pharmaceuticals: Turning the Tables on Cancer with The - 3BL Media
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Sees Large Decrease in Short Interest - MarketBeat
Institute for Wealth Management LLC. Makes New $260,000 Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals CEO Bruce Cozadd sells shares worth $183,465 - MSN
Insider Sell: Bruce Cozadd Sells Shares of Jazz Pharmaceuticals PLC - GuruFocus.com
Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by BTC Capital Management Inc. - MarketBeat
Robeco Institutional Asset Management B.V. Raises Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Leerink Partnrs Has Strong Forecast for JAZZ FY2024 Earnings - MarketBeat
KBC Group NV Increases Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Jazz Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire
Jazz Pharmaceuticals (NASDAQ:JAZZ) investors are sitting on a loss of 14% if they invested five years ago - Simply Wall St
Narcolepsy Market Future Business Opportunities 2025-2032 | - openPR
Pacer Advisors Inc. Purchases 115,102 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Investor Network: Jazz Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire
Perpetual Ltd Sells 81,043 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Lmcg Investments LLC Takes $5.60 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
MassMutual Private Wealth & Trust FSB Has $2.19 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
2,442 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Aaron Wealth Advisors LLC - MarketBeat
Arkadios Wealth Advisors Invests $716,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Short Interest Update - MarketBeat
Kera Capital Partners Inc. Buys New Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Wedge Capital Management L L P NC Sells 48,679 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Empirical Asset Management LLC Invests $5.36 Million in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Hennion & Walsh Asset Management Inc. Has $4.42 Million Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Burney Co. Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline - MSN
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
JAZZ (Jazz Pharmaceuticals) Growth Rank : 7 (As of Jan. 15, 2025) - GuruFocus.com
Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):